SRP-1003 IV Infusion clinical trials

Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy

This study is testing a new medicine called SRP-1003 for people with a muscle condition called Type 1 Myotonic Dystrophy. Researchers want to see if it's safe, how the body handles it, and if it might help. It's compared to a dummy medicine to understand its effects better.